What is the Current Share Price of Aurobindo Pharma Ltd?
- Answer Field
-
Aurobindo Pharma Ltd share price is for NSE ₹ 1,547.50 & for BSE ₹ 1,551.80 as on Jun 29 2026 03:30 PM.
Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply
AUROBINDO PHARMA LTD is currently trading at ₹1547.5, down by ₹7.69 from the previous close. The stock touched an intraday high of ₹1585.30 and a low of ₹1538.10 during the latest trading session. Over the past one year, AUROBINDO PHARMA LTD has delivered a return of 38.83%, while the stock has gained 6.91% in the last one month.
| Particulars | MAR 2026 (Values in Cr) |
|---|---|
| Revenue | 2746.98 |
| Operating Expense | 2124.33 |
| Net Profit | 692.23 |
| Net Profit Margin (%) | 25.19 |
| Earnings Per Share (EPS) | 11.92 |
| EBITDA | 995.51 |
| Effective Tax Rate (%) | 21.00 |
| Company Name | Price | P/E | P/B | Market Cap | 52 Week Low | 52 Week High |
|---|---|---|---|---|---|---|
| AMBALAL SARABHAI ENT L | 31.51 | 13.02 | 1.52 | 241.47 | 23.12 | 38.85 |
| BLISS GVS PHARMA LTD | 492.50 | 39.98 | 4.37 | 5223.27 | 118.35 | 495.00 |
| CIPLA LTD | 1440.30 | 30.57 | 3.37 | 116353.96 | 1165.55 | 1672.20 |
| FERMENTA BIOTECH LIMITED | 365.50 | 16.12 | 2.64 | 1075.70 | 256.40 | 399.00 |
| Company Name | Price | P/E | P/B | Market Cap | 52 Week Low | 52 Week High |
|---|---|---|---|---|---|---|
| AMBALAL SARABHAI ENT L | 31.51 | 22.03 | 4.05 | 241.47 | 23.12 | 38.85 |
| AMRUTAJAN HEALTH LTD | 538.05 | 24.12 | 4.20 | 1555.54 | 490.00 | 789.95 |
| ASTRAZENECA PHARMA INDIA LTD. | 8382.65 | 109.48 | 24.01 | 20956.63 | 7630.00 | 9850.00 |
| BLISS GVS PHARMA LTD | 492.50 | 53.13 | 4.52 | 5223.27 | 118.35 | 495.00 |
Aurobindo Pharma reported Q2 revenue of ₹7,796 crore for this financial year, reflecting a YoY growth of 7.99%. Operating profit reached ₹1,566 crore with an OPM of 20%. Profit after tax stood at ₹817 crore, a YoY growth of 9%, despite a sequential dip from Q1 of this year. Over the last decade, compounded sales growth was 14%, and profit growth was 11%. Return on equity, over the same period was 16%.
For FY24, Aurobindo Pharma achieved a 16.68% sales growth, reaching ₹29,002 crore compared to ₹24,859 crore in FY23. Net profit stood at ₹3,169 crore, highlighting moderate recovery despite lower profitability over recent years. EPS for the year was ₹54.15. The company’s 10-year compounded profit growth averaged 11%, but three-year growth remained stagnant at -1%. Return on equity, though stable, declined to 12% last year, reflecting the challenges in maintaining margins in a competitive sector. Aurobindo Pharma’s share price saw an increase of 19% in the last 1-year period.
Aurobindo Pharma’s dividend payout declined to 8% in FY24, down from 23% in FY23, indicating a shift in financial priorities. The dividend yield for the year stood at a modest 0.37%. While the company’s long-term growth in sales and profits is robust, recent profit stagnation (-1% compounded growth over three years) and declining returns on equity have impacted dividend trends.
1. Who is the CEO of Aurobindo Pharma Ltd?
Mr. K. Nithyananda Reddy is the Vice Chairman and Managing Director of Aurobindo Pharma Ltd. He oversees the company’s operations and global pharmaceutical initiatives.
2. When was Aurobindo Pharma Ltd established?
Aurobindo Pharma Ltd was established in 1986 and has grown into a prominent pharmaceutical company with a significant presence in both domestic and international markets.
3. What factors influence the Aurobindo Pharma Share Price?
Aurobindo Pharma’s share price is influenced by factors such as regulatory approvals, the launch of new pharmaceutical products, revenue growth, and global market conditions for generics and APIs.
4. Is Aurobindo Pharma Ltd debt free?
No, Aurobindo Pharma Ltd is not debt free, as it utilises borrowings to support its manufacturing, research, and global expansion efforts.
5. What is the CAGR of Aurobindo Pharma Share?
The CAGR of Aurobindo Pharma’s share is 8% over 10 years, 22% over 5 years, and 22% over 3 years.
6. How has the Aurobindo Pharma Share Price performed over the past year?
Over the past year, Aurobindo Pharma’s share price has increased by 19%, reflecting improved business performance and market sentiment toward its pharmaceutical offerings.
Sign-in to trade with your demat account, or set up a new demat account for free
Aurobindo Pharma Ltd share price is for NSE ₹ 1,547.50 & for BSE ₹ 1,551.80 as on Jun 29 2026 03:30 PM.
The market cap of Aurobindo Pharma Ltd for NSE ₹ 0.00 & for BSE ₹ 0.00 as on Jun 29 2026 03:30 PM.
The 52 Week High and Low of Aurobindo Pharma Ltd for NSE is ₹ 1,585.30 and ₹ 1,016.10 and for BSE is ₹ 1,585.55 and ₹ 1,017.00.
The 1 year returns on the stock has been 38.83%.
As on Jun 29 2026 03:30 PM the price-to-earnings (PE) ratio for Aurobindo Pharma Ltd share is 37.40.
As on Jun 29 2026 03:30 PM, the price-to-book (PB) ratio for Aurobindo Pharma Ltd share is 391.14.
You can trade in Aurobindo Pharma Ltd shares with Bajaj Broking by opening a demat account.
To buy Aurobindo Pharma Ltd shares on the Bajaj Broking app, follow these steps:
• Login to the Bajaj Broking App
• Click on the Search Icon
• Search “Aurobindo Pharma Ltd”
• Click on the BUY icon
• Place a buy order specifying the desired quantity of shares.
• Click BUY again to complete the purchase
No results found